The immunohistochemical (IHC) staining showed that the high expression of SLC16A1-AS1 was associated with elevated levels of SLC16A1 and CD206 while exhibiting reduced expression of CD86 in HCC tissues (Fig. 9G and Supplementary Fig. S9A). The gene discussed is CD86; the disease is hepatocellular carcinoma.